newsfilter
← Latest News
GlobeNewswire·

Jounce Therapeutics Appoints Jigar Raythatha to its Board of Directors

CAMBRIDGE, Mass., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ:JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced the appointment o